BioInsights - Immuno-oncology: manufacturing and commercial business models for the new decade - spotlight

CELL & GENE THERAPY INSIGHTS

Immuno-oncology: manufacturing and commercial business models for the new decade

Usman Azam

Guest Editor:

Usman Azam, President & CEO at Tmunity Therapeutics Inc

July 2020

Download full spotlight

Decentralized manufacturing: from stem cell transplants to the next generation of cellular immunotherapies

M Li,

S Kassim

18 June 2020

Expert Insight

Read more
Immuno-oncology: manufacturing and commercial business models for the new decade – Foreword

U Azam

28 July 2020

Foreword

Read more
Expert Roundtable: evolving autologous and allogeneic cell therapy manufacturing models in the commercial setting

D Adams,

G Russotti,

J Lunger et al.

17 July 2020

Expert Roundtable Video

Watch now
Simplifying GMP CART and CAR NK cell therapy manufacturing processes

S Dluczek,

K Fynes,

S Fricke et al.

16 July 2020

Innovator Insight

Read more
Evolving autologous and allogeneic cell therapy manufacturing models in the commercial setting

D Adams,

G Russotti,

J Lunger et al.

16 July 2020

Expert Roundtable

Read more
Manufacturing of endogenous, non-engineered, antigen specific T cells against tumor targets

Ali Mohamed, Vice President, CMC at Immatics

Megan Ciarlo, Technology & Applications Specialist at Miltenyi Biotec

14 July 2020

Webinar

Watch now
Current and future directions for tumor infiltrating lymphocyte therapy for the treatment of solid tumors

M Fardis,

K DiTrapani,

F Finckenstein et al.

3 July 2020

Expert Insight

Read more
Innovating CAR T cell therapy for today and tomorrow

D Chang

30 June 2020

Expert Insight

Read more
Immuno-oncology cell therapies: commercial considerations and strategies for the new decade

G Firestone

30 June 2020

Expert Insight

Read more
Commercialization of TCR T-cell therapy: patient journey implications

K Freeman

17 June 2020

Expert Insight

Read more
Looking to the future of stem cell-derived immunotherapy

P Zandstra

17 June 2020

Interview

Read more
Understanding the drivers of success and failure in CAR T cell therapy

J Melenhorst

16 June 2020

Interview

Read more
Challenges of cell collections for cell therapy manufacturing: what do we want in the bag?

Elizabeth Valdez, RN & MSN Global Trainer at Terumo BCT

Jim Beltzer, Global Strategy Lead, Cell Therapy

Sandeep Soni, Associate Professor, Pediatric Stem Cell Transplant, Gene Therapy & Regenerative Medicine at Stanford University School of Medicine

Melinda Caltabiano, Director, Apheresis Operations at Dendreon Pharmaceuticals

Krishnendu Roy, Professor, Director, Marcus Center for Therapeutic Cell Characterization & Manufacturing (MC3M) at Georgia Institute of Technology

24 June 2020

Webinar

Watch now
Simplifying GMP CAR-T and CAR NK cell therapy manufacturing processes

Martha Luevano, Global Product Manager at Miltenyi Biotec

Xiuyan Wang, Assistant Director, Michael G. Harris Cell Therapy & Cell Engineering Facility at Memorial Sloan-Kettering Cancer Center

Stephan Fricke, Head of GMP Process Development at Fraunhofer Institute for Cell Therapy & Immunology IZI

Sarah Dluczek, Technical Leader, GMP Unit at Fraunhofer Institute for Cell Therapy & Immunology IZI

Kate Fynes, Process Development Investigator, Cell & Gene Therapy CMC at GlaxoSmithKline

Ulrike Koehl, Director & Head, Institute of Cell Therapeutics & GMP Development Unit at Hannover Medical School

9 June 2020

Webinar

Watch now